Home

MITCHELL J MD BLUTT

CIK 1097955 · last filed 2021-05-19

MITCHELL J MD BLUTT is a corporate insider who has filed 22 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for CHFW.WS, was dated May 19, 2021. Across all open-market trades the lifetime net is −$20.2M, making them a net seller over the disclosed history. 7 SEC filings were submitted jointly with Consonance Capman GP, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

22

Lifetime Open-Market Net

-$20.22M

Filer Profile

Reported Address
1370 AVENUE OF THE AMERICA
SUITE 3301
NEW YORK, NY 10019
Related Filers
Consonance Capman GP, LLC — 7 joint filings, latest 2022-12-15
Life Sciences Consonance — 1 joint filings, latest 2022-12-15
Kevin Harold Livingston — 1 joint filings, latest 2022-12-15
Benny Soffer — 1 joint filings, latest 2022-12-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Surrozen, Inc./DE (CHFW.WS) Delisted Director 434,000 $1.16 $503.4K -$981 2 2021-05-19
Surrozen, Inc./DE (CHFW.U) Delisted Director 128,900 $9.55 $1.23M $0 3 2020-12-04
QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Director 226,968 — — -$20.82M 12 2012-09-06
DJO INC (PXR) Delisted Director 115,340 — — $597.0K 4 2007-06-06

Recent Filings

22 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-05-19 Surrozen, Inc./DE (CHFW.WS) Delisted Grant (A) +24,000 $0 EDGAR
2021-05-19 Surrozen, Inc./DE (CHFW.WS) Delisted Mixed +2,620,000 $24.2K EDGAR
2020-12-04 Surrozen, Inc./DE (CHFW.U) Delisted Buy (P) +4,000,000 $0 EDGAR
2020-12-03 Surrozen, Inc./DE (CHFW.U) Delisted Buy (P) +24,000 $0 EDGAR
2020-11-25 Surrozen, Inc./DE (CHFW.U) Delisted Buy (P) +410,000 $0 EDGAR
2012-09-06 QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Mixed −10,000 -$992.0K EDGAR
2012-07-05 QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Sell (S) −70,000 -$3.72M EDGAR
2012-05-14 QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Grant (A) — $0 EDGAR
2012-05-07 QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Mixed — -$376.5K EDGAR
2012-05-04 QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Sell (S) −79,952 -$3.51M EDGAR
Showing 1–10 of 22
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.